title: No influence of intravenous ciprofloxacin on histamine release, complement activation, and blood clotting system.
authors.affiliation: Institute of Clinical Pharmacology, Bayer AG, Pharma Research Center - 5600 Wuppertal, FRG.
authors.forename: W
authors.initials: W
authors.lastname: Wingender
authors.forename: D
authors.initials: D
authors.lastname: Beermann
authors.forename: I
authors.initials: I
authors.lastname: Konrad-Dalhoff
authors.forename: I
authors.initials: I
authors.lastname: Loof
authors.forename: P
authors.initials: P
authors.lastname: Eckert
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D003167:Complement Activation / Q000187:drug effects*; D005174:Factor XII / Q000378:metabolism; D006632:Histamine / Q000097:blood; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male
chemical_list: D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D006632:Histamine; D000990:Antithrombin III; D005174:Factor XII